The effect of halothane on SGOT and SGPT of operating room personnel

Pakistan Journal of Biological Sciences

Volumn 9, Issue 2, 2006, Pages 299-301

  Nasiri, Ebrahim ^a   Hosseinimehr, Seyed Jalal ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anesthesia staff; Disease; Halothane; Liver

Indexed keywords

EID: 33644645563     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2006.299.301     Document Type: Article

References (16)

1. Belge, E., G. Yuregir and I. Tuncer, 2000. The effect of halothane on enzymatic activity of mouse liver and erythrocyte glucose-6-phophate dehydogenase. Turk. J. Med. Sci., 30: 219-222.
2. Boivin, J.F., 1997. Risk of spontaneous abortion in women occupationally exposed to anesthetic gases: A meta-analysis. Occup. Environ. Med., 54: 541-548.
3. Cho, Y.H., J.C. Lee, B.S. Choi and Y.J. Yoon, 1989. The effects of halothane, enflurane and regional anesthesia on SGOT and SGPT. Korean J. Anesthesiol., 22 : 892-905.
4. Daghfous, R., S. Aidli and M. Sfaxi, 2003. Halothane-induced hepatitis. 8 case reports. Tunis. Med., 81: 874-578.
5. Elioh, R.H. and L. Strunin, 1993. Hepatotoxicity of volatile anesthetic. Br. J. Anesth., 70: 339-348.
6. Giannini, E.G., R. Testa and V. Savarino, 2005. Liver enzyme alteration: a guide for clinicians. Can. Med. Assoc., 172: 367-379.
7. Hasan, F., 1998. Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis. Hepatogastroenterology, 45: 518-522.
8. Kharasch, E.D. and D. Hankins, 1996. Identification of enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet, 347: 1367-1371.
9. Knight, J.A., 2005. Liver function tests: their role in the diagnosis of hepatobiliary diseases. J. Infus. Nurs., 28:108-117.
10. McEven, M.M., R.D. Gleed, W. Ludder and T. Stokol, 2000. Hepatic effects of halothane and isoflurane anesthesia in goats. J. Am. Vet. Med. Assoc., 217: 1697-1700.
11. Minoda, Y. and E. Kharasch, 2001. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Aneathesiology, 95: 509-514.
12. Neuberger, J. and S.R. William, 1988. Halothane hepatitis. Diges. Dis., 6: 52-64.
13. Ray, D.C. and G.B. Drummond, 1991. Halothane hepatitis. Br. J. Anaesth., 67: 84-99.
14. Rodes, J. and M. Bruguera, 2001. The uses of error: iatrogenic hepatitis. Lancet, 357: 791.
15. Spracklin, D.K., K.E. Thummel and E.D. Kharasch, 1996. Human reductive halothane metabolism in vitro is catalyzed by cytochrom P4502A6 and 3A4. Drug Metab. Dispos., 24: 976-983.
16. Topal, A., N. Gul, Y. Licol and OS. Gorgul, 2003. Hepatic effects of halothane, isoflurane or sevoflurane anesthesia in dogs. J. Vet. Med., 50: 530-533.